| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |